U.S. investment in China

American companies caught in the middle of China-U.S. competition should remember: all geopolitics is local.

A little-noticed bill introduced in the U.S. Congress has the potential to chill American investors’ appetite for Chinese assets. 

While China’s global growth story is hitting a rough patch, in Asia, we’ve now officially entered the era of Japan’s revitalization. 

China’s signals that its economy is open for business and tourism are increasingly urgent, but will they be effective?

Xi’s transformation from “wolf warrior” to “panda” was more about what came after the summit: a major gathering with American CEOs.

To attract foreign investment, the Chinese healthcare and biopharma sectors are more open for business than ever – or at least they claim to be. But challenges exist beneath the surface.

A visit to China by the U.S. commerce secretary saw more deliverables than any other recent exchange, but there are still hard limits on what can be achieved.

The order will block U.S. investments in Chinese companies working on advanced computer chips, micro electronics, quantum information technologies, and artificial intelligence.

U.S. businesses need to consider the impact of a physical conflict on their Chinese production and distribution bases.

Insights from Jean-Marc F. Blanchard.

It is Trump’s first major action toward China since he lost his reelection bid to challenger Joe Biden.